Cargando…
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
INTRODUCTION: The prime-boost COVID-19 mRNA vaccination strategy has proven to be effective against severe COVID-19 disease and death. However, concerns have been raised due to decreasing neutralizing antibody levels after COVID-19 vaccination and due to the emergence of new immuno-evasive SARS-CoV-...
Autores principales: | Belik, Milja, Liedes, Oona, Vara, Saimi, Haveri, Anu, Pöysti, Sakari, Kolehmainen, Pekka, Maljanen, Sari, Huttunen, Moona, Reinholm, Arttu, Lundberg, Rickard, Skön, Marika, Österlund, Pamela, Melin, Merit, Hänninen, Arno, Hurme, Antti, Ivaska, Lauri, Tähtinen, Paula A., Lempainen, Johanna, Kakkola, Laura, Jalkanen, Pinja, Julkunen, Ilkka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899862/ https://www.ncbi.nlm.nih.gov/pubmed/36756112 http://dx.doi.org/10.3389/fimmu.2023.1099246 |
Ejemplares similares
-
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination
por: Jalkanen, Pinja, et al.
Publicado: (2022) -
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
por: Hurme, Antti, et al.
Publicado: (2022) -
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants
por: Belik, Milja, et al.
Publicado: (2022) -
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up
por: Hurme, Antti, et al.
Publicado: (2023) -
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
por: Jalkanen, Pinja, et al.
Publicado: (2021)